Curocell Inc. (KOSDAQ:372320)
South Korea · Delayed Price · Currency is KRW 22,850
+1,200 (5.54%)
At close: Oct 1, 2026
Curocell Market Cap
Curocell has a market cap or net worth of 347.94 billion as of October 1, 2026. Its market cap has decreased by -41.27% in one year.
Market Cap
347.94B
Enterprise Value
325.90B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
22,850.00
ChartMarket Cap Chart
Since November 9, 2023, Curocell's market cap has increased from 295.40B to 347.94B, an increase of 17.79%. That is a compound annual growth rate of 5.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 347.94B | -46.37% |
| Dec 30, 2025 | 648.75B | 47.92% |
| Dec 30, 2024 | 438.58B | -10.00% |
| Dec 28, 2023 | 487.34B | 64.98% |
| Nov 9, 2023 | 295.40B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AprilBio | 514.42B |
| ROKIT Healthcare | 507.91B |
| Inventage Lab | 318.05B |
| IMBiologics | 262.16B |
| IntoCell | 256.88B |
| HansBiomed | 253.57B |
| S.Biomedics | 249.56B |
| Genome & Company | 242.93B |